BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 29257776)

  • 1. Asthma versus chronic obstructive pulmonary disease, the Dutch versus British hypothesis, and role of interleukin-5.
    Chambliss JM; Sur S; Tripple JW
    Curr Opin Allergy Clin Immunol; 2018 Feb; 18(1):26-31. PubMed ID: 29257776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibody therapy for the treatment of asthma and chronic obstructive pulmonary disease with eosinophilic inflammation.
    Nixon J; Newbold P; Mustelin T; Anderson GP; Kolbeck R
    Pharmacol Ther; 2017 Jan; 169():57-77. PubMed ID: 27773786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-5 pathway inhibition in the treatment of eosinophilic respiratory disorders: evidence and unmet needs.
    Varricchi G; Bagnasco D; Borriello F; Heffler E; Canonica GW
    Curr Opin Allergy Clin Immunol; 2016 Apr; 16(2):186-200. PubMed ID: 26859368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biologics targeting IL-5, IL-4 or IL-13 for the treatment of asthma - an update.
    Walsh GM
    Expert Rev Clin Immunol; 2017 Feb; 13(2):143-149. PubMed ID: 27459348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgE and eosinophils as therapeutic targets in asthma.
    Patel TR; Sur S
    Curr Opin Allergy Clin Immunol; 2017 Feb; 17(1):42-49. PubMed ID: 27906698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asthma-chronic obstructive pulmonary disease overlap syndrome: a controversial concept.
    Rodrigo GJ; Neffen H; Plaza V
    Curr Opin Allergy Clin Immunol; 2017 Feb; 17(1):36-41. PubMed ID: 27841767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS): opportunities and challenges.
    Barrecheguren M; Esquinas C; Miravitlles M
    Curr Opin Pulm Med; 2015 Jan; 21(1):74-9. PubMed ID: 25405671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between inflammatory markers and spirometric parameters in ACOS, Asthma, and COPD.
    Uzan GC; Borekci S; Doventas YE; Koldas M; Gemicioglu B
    J Asthma; 2020 Dec; 57(12):1273-1279. PubMed ID: 31403365
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical approaches towards asthma and chronic obstructive pulmonary disease based on the heterogeneity of disease pathogenesis.
    Hizawa N
    Clin Exp Allergy; 2016 May; 46(5):678-87. PubMed ID: 27009427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-4/interleukin-13 versus interleukin-5: a comparison of molecular targets in biologic therapy for the treatment of severe asthma.
    Wu AY; Sur S; Grant JA; Tripple JW
    Curr Opin Allergy Clin Immunol; 2019 Feb; 19(1):30-37. PubMed ID: 30407206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asthma-COPD Overlap Syndrome (ACOS): Single disease entity or not? Could exhaled nitric oxide be a useful biomarker for the differentiation of ACOS, asthma and COPD?
    Karampitsakos T; Gourgoulianis KI
    Med Hypotheses; 2016 Jun; 91():20-23. PubMed ID: 27142135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changing Paradigms in the Treatment of Severe Asthma: The Role of Biologic Therapies.
    Katial RK; Bensch GW; Busse WW; Chipps BE; Denson JL; Gerber AN; Jacobs JS; Kraft M; Martin RJ; Nair P; Wechsler ME
    J Allergy Clin Immunol Pract; 2017; 5(2S):S1-S14. PubMed ID: 28143691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biologics in the treatment of severe asthma.
    Quirce S; Phillips-Angles E; Domínguez-Ortega J; Barranco P
    Allergol Immunopathol (Madr); 2017 Dec; 45 Suppl 1():45-49. PubMed ID: 29108767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subclinical phenotypes of asthma.
    Bradding P; Green RH
    Curr Opin Allergy Clin Immunol; 2010 Feb; 10(1):54-9. PubMed ID: 19907311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asthma-COPD overlap syndrome (ACOS): A diagnostic challenge.
    Tho NV; Park HY; Nakano Y
    Respirology; 2016 Apr; 21(3):410-8. PubMed ID: 26450153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mepolizumab in the treatment of severe eosinophilic asthma.
    Fainardi V; Pisi G; Chetta A
    Immunotherapy; 2016; 8(1):27-34. PubMed ID: 26653083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Airflow obstruction: is it asthma or is it COPD?
    Rogliani P; Ora J; Puxeddu E; Cazzola M
    Int J Chron Obstruct Pulmon Dis; 2016; 11():3007-3013. PubMed ID: 27942210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are Asthma and COPD a Continuum of the Same Disease?
    Soler X; Ramsdell JW
    J Allergy Clin Immunol Pract; 2015; 3(4):489-95; quiz 496-7. PubMed ID: 26164572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory endotypes in COPD.
    Barnes PJ
    Allergy; 2019 Jul; 74(7):1249-1256. PubMed ID: 30834543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Essential Mechanisms of Differential Activation of Eosinophils by IL-3 Compared to GM-CSF and IL-5.
    Esnault S; Kelly EA
    Crit Rev Immunol; 2016; 36(5):429-444. PubMed ID: 28605348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.